Cerebral and Tissue Oximetry Device Market Outlook:
Cerebral and Tissue Oximetry Device Market size was over USD 190.22 million in 2025 and is poised to exceed USD 377.7 million by 2035, witnessing over 7.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of cerebral and tissue oximetry device is estimated at USD 202.38 million.
A significant market driver is the increasing number of surgical procedures performed in traditional operating rooms and outpatient settings. In view of the increasing number of complex procedures, cerebral and tissue oximetry device play an important role in the monitoring of tissue oxygen levels during surgery, enabling surgeons to make informed decisions and potentially reduce complications. In comparison with the global estimate of 5000 surgeries for every 100,000 people, a total of 3646 procedures are expected each year to meet the needs of India's population.
The demand for cerebral and tissues oximetry devices is driven by a growing preference to non-invasive medical surveillance. These technologies are used by both patients and healthcare professionals, because they allow the provision of Realtime data that does not involve inoperative procedures, improve patient comfort and reduce potential risks resulting from traditional methods.
Key Cerebral and Tissue Oximetry Device Market Insights Summary:
Regional Highlights:
- North America cerebral and tissue oximetry device market will secure over 35% share, fueled by increased incidence of heart disease and more FDA approvals, forecast period 2026–2035.
- Europe market will exhibit significant CAGR, fueled by a growing burden of chronic diseases requiring oxygen saturation monitoring, forecast period 2026–2035.
Segment Insights:
- The tabletop segment in the cerebral and tissue oximetry device market is expected to hold a 60% share by 2035, fueled by ease of use, user-friendly interfaces, and high adoption across healthcare facilities.
- The hospitals segment in the cerebral and tissue oximetry device market is projected to hold a 40% share by 2035, driven by the adoption of oximetry devices in critical care settings to enhance real-time monitoring.
Key Growth Trends:
- Growing Technological Advancement
- Growing Integration of Home Healthcare
Major Challenges:
- Growing Technological Advancement
- Growing Integration of Home Healthcare
Key Players: of Brain Scientific Inc., Masimo Corp., Medtronic Plc, Moor Instruments Ltd., Nihon Kohden Corporation, Sotera Health Co..
Global Cerebral and Tissue Oximetry Device Market Forecast and Regional Outlook:
Market Size & Growth Projections:
- 2025 Market Size: USD 190.22 million
- 2026 Market Size: USD 202.38 million
- Projected Market Size: USD 377.7 million by 2035
- Growth Forecasts: 7.1% CAGR (2026-2035)
Key Regional Dynamics:
- Largest Region: North America (35% Share by 2035)
- Fastest Growing Region: Asia Pacific
- Dominating Countries: United States, China, Japan, Germany, France
- Emerging Countries: China, India, Japan, South Korea, Brazil
Last updated on : 16 September, 2025
Cerebral and Tissue Oximetry Device Market Growth Drivers and Challenges:
Growth Drivers
- Growing Technological Advancement - The growth of cerebral and tissue oximetry device market is driven by continuous technological progress. The development of more effective and precise monitoring solutions is supported by advances in sensor technology, increased data analysis capabilities as well as wireless connectivity. These advances in technology are attracting healthcare providers seeking state-of-the-art tools to improve patient care.
- Growing Integration of Home Healthcare - A significant growth opportunity exists for cerebral and tissue oximetry device as a result of the trend towards home healthcare. Patients can manage their health condition from the comfort of their homes, thanks to recent advances in mobile and user-friendly monitoring systems. By developing devices to meet the specific requirements of home healthcare settings, market players can benefit from such an evolving landscape.
- Partnerships for Research and Development - Strategic growth opportunities exist through collaboration between industry players and research institutions. Companies can speed up the development of new technologies and enhance their use in cerebral and tissue oximetry device by sharing resources and experience. Through the introduction of cutting-edge solutions, such collaboration can foster breakthroughs that address existing limitations and drive growth in the cerebral and tissue oximetry device market
Challenges
- High Cost of Device - The high cost of cerebral and tissue oximetry device is holding back the market. For smaller healthcare facilities and emerging markets, initial investment and maintenance costs may be too high to be widely adopted. Market players who seek to provide a wide range of healthcare services are confronted with this financial constraint.
- Limited Reimbursement Policies are set to hinder the market growth in the forecast period.
- Concerns associated with its accuracy is expected to pose limitation on the cerebral and tissue oximetry device market growth in the forecast period
Cerebral and Tissue Oximetry Device Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
7.1% |
|
Base Year Market Size (2025) |
USD 190.22 million |
|
Forecast Year Market Size (2035) |
USD 377.7 million |
|
Regional Scope |
|
Cerebral and Tissue Oximetry Device Market Segmentation:
Application Segment Analysis
Based on application, the hospital segment is predicted to account for 40% share of the global cerebral and tissue oximetry device market during forecast period 2026-2035. The market was led by hospitals, which were the main end users as they play a central role in patients' care and are responsible for managing critical conditions. In order to enhance real-time monitoring and allow healthcare professionals to make timely decisions, these medical facilities have adopted oximetry devices for cerebral and tissue. In particular in surgery and intensive care settings, these devices have proven to be an important element of ensuring the optimum oxygen level for patients.
Type Segment Analysis
In terms of type, the tabletop segment in cerebral and tissue oximetry device market is set to account for the highest share of 60% by the end of 2035. The ease of use and accessibility is offered by Tabletop oximetry devices, which are placed in a convenient location on surfaces such as tables or counters. They are of particular benefit to healthcare professionals for their stable and proven ability to monitor oxygen levels in the brain and tissues. The widespread adoption of table top equipment in various healthcare settings is facilitated by user friendly interfaces and intuitive controls.
Our in-depth analysis of the global cerebral and tissue oximetry device market includes the following segments:
|
Type |
|
|
Application |
|
|
Technology |
|
|
End-User |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Cerebral and Tissue Oximetry Device Market Regional Analysis:
North American Market Insights
The cerebral and tissue oximetry device market in the North America region is set to hold the largest revenue share of 35% by the end of the forecast period. The increased incidence of heart disease, the increasing number of cardiac surgeries and an increase in US Food and Drug Administration approval of accessories enabling tissue oximetry systems to be compatible with each other are major factors driving market growth. The US Food and Drug Administration approved HemoSphere CX, a product of Edwards Lifesciences Corporation, in September 2019. It's a smart cable that allows HemoSphere's advanced monitoring platform and ForeSight's tissue oximetry sensors to be compatible. Moreover, the robust growth of technology and an increasing number of new products are being introduced into the healthcare industry In North America, the increasing number of R&D activities is driving market growth. The expansion of the regional market is also being fueled by the rise in US FDA certifications and approvals for cerebral and tissue oximetry device in the area. The popularity of the devices is also rising in the region due to the existence of several well-known suppliers that offer technologically sophisticated goods, such as Nonin Medical, Edwards Lifesciences, ISS, Masimo, and HyperMed Imaging.
European Market Insights
The cerebral and tissue oximetry device market in the Europe region is set to grow significantly by the end of projected period. Europe faces a growing burden of chronic diseases such as cardiovascular diseases, chronic obstructive pulmonary disease, and peripheral artery disease. These conditions often require monitoring of oxygen saturation levels in different tissues, which is where cerebral and tissue oximetry device come in. Nearly one third of individuals aged over 15 a long-time report living with two or more chronic non-communicable infections, 37% of Europeans matured 65 and over have different chronic conditions. Furthermore, the growing focus on minimally invasive procedures in healthcare is creating a demand for smaller and more portable cerebral and tissue oximetry device that can be used during surgery or other procedures.
Cerebral and Tissue Oximetry Device Market Players:
- Artinis Medical Systems
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Edwards Lifesciences Corp.
- Hamamatsu Photonics KK
- HyperMed Imaging Inc.
- Brain Scientific Inc.
- Masimo Corp.
- Medtronic Plc
- Moor Instruments Ltd.
- Nihon Kohden Corporation
- Sotera Health Co.
Recent Developments
- The acquisition of Brain Scientific, a company specialising in cerebral oximetry monitoring, was announced by Masimo, a global leader in pulse oximetry and patient monitoring technology, in November 2023. This step will reinforce Masimo's position on the market for brain monitoring and broaden its range of non-invasive detection technologies.
- BrainOx, a medical technology company specialising in cerebral oximetry systems and Nihon Kohden, the leading manufacturer of medical devices, signed an agreement to develop and market solutions for monitoring cerebral oximetry on August 23, 2023. This collaboration with Nihon Kohdens' experience in the production and distribution of medical devices aims to take advantage of BrainOx expertise on brain oximetry technology.
- Report ID: 5837
- Published Date: Sep 16, 2025
- Report Format: PDF, PPT
- Get detailed insights on specific segments/region
- Inquire about report customization for your industry
- Learn about our special pricing for startups
- Request a demo of the report’s key findings
- Understand the report’s forecasting methodology
- Inquire about post-purchase support and updates
- Ask About Company-Level Intelligence Additions
Have specific data needs or budget constraints?
Inquiry Before BuyingFrequently Asked Questions (FAQ)
Cerebral and Tissue Oximetry Device Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
Copyright @ 2025 Research Nester. All Rights Reserved.
